FDAnews Drug Daily Bulletin

Paladin Acquires Products From Shire

May 4, 2007
A A

Paladin Labs Inc., through its wholly owned subsidiary, Squire Pharmaceuticals Inc. announced that it has entered into an agreement with Shire BioChem Inc., Shire US Inc. Shire US Manufacturing Inc. and Shire LLC to acquire a total of eight products currently marketed in Canada by Shire BioChem Inc.
CCN Matthews